Efferocytosis: An Emerging Therapeutic Strategy for Type 2 Diabetes Mellitus and Diabetes Complications

References

• Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell. 2011;147(4):742–758. doi:10.1016/j.cell.2011.10.033
   PubMed Web of Science ®Google Scholar
• Ge Y, Huang M, Yao YM. Efferocytosis and Its Role in Inflammatory Disorders Front Cell Dev Biol. 2022;10:839248.
   Google Scholar
• Doran AC, Yurdagul A Jr, Tabas I. Efferocytosis in health and disease. Nat Rev Immunol. 2020;20(4):254–267. doi:10.1038/s41577-019-0240-6
   PubMed Web of Science ®Google Scholar
• Zhang J, Ding W, Zhao M, et al. Mechanisms of efferocytosis in determining inflammation resolution: therapeutic potential and the association with cardiovascular disease. Br J Pharmacol. 2022;179(23):5151–5171. doi:10.1111/bph.15939
   PubMed Web of Science ®Google Scholar
• Mahmoudi A, Firouzjaei AA, Darijani F, et al. Effect of diabetes on efferocytosis process. Mol Biol Rep. 2022;49(11):10849–10863. doi:10.1007/s11033-022-07725-2
   PubMed Web of Science ®Google Scholar
• Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep. 2013;13(3):435–444. doi:10.1007/s11892-013-0375-y
   PubMed Web of Science ®Google Scholar
• Tomic D, Shaw JE, Magliano DJ. The burden and risks of emerging complications of diabetes mellitus. Nat Rev Endocrinol. 2022;18(9):525–539. doi:10.1038/s41574-022-00690-7
   PubMed Web of Science ®Google Scholar
• Mao QY, He SY, Hu QY, et al. Advanced Glycation End Products (AGEs) inhibit macrophage efferocytosis of apoptotic β cells through binding to the receptor for AGEs. J Immunol. 2022;208(5):1204–1213. doi:10.4049/jimmunol.2100695
   PubMed Web of Science ®Google Scholar
• Tajbakhsh A, Gheibihayat SM, Karami N, et al. The regulation of efferocytosis signaling pathways and adipose tissue homeostasis in physiological conditions and obesity: current understanding and treatment options. Obes Rev. 2022;23(10):e13487. doi:10.1111/obr.13487
   PubMed Web of Science ®Google Scholar
• Juban G, Chazaud B. Efferocytosis during skeletal muscle regeneration. Cells. 2021;10(12):3267. doi:10.3390/cells10123267
   PubMed Web of Science ®Google Scholar
• Horst AK, Tiegs G, Diehl L. Contribution of macrophage efferocytosis to liver homeostasis and disease. Front Immunol. 2019;10:2670. doi:10.3389/fimmu.2019.02670
   PubMed Web of Science ®Google Scholar
• Lauber K, Bohn E, Kröber SM, et al. Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell. 2003;113(6):717–730. doi:10.1016/s0092-8674(03)00422-7
   PubMed Web of Science ®Google Scholar
• Gude DR, Alvarez SE, Paugh SW, et al. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a “come-and-get-me” signal. FASEB j. 2008;22(8):2629–2638. doi:10.1096/fj.08-107169
   PubMed Web of Science ®Google Scholar
• Truman LA, Ford CA, Pasikowska M, et al. CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood. 2008;112(13):5026–5036. doi:10.1182/blood-2008-06-162404
   PubMed Web of Science ®Google Scholar
• Elliott MR, Chekeni FB, Trampont PC, et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature. 2009;461(7261):282–286. doi:10.1038/nature08296
   PubMed Web of Science ®Google Scholar
• Yang WJ, Cao RC, Xiao W, et al. Acinar ATP8b1/LPC pathway promotes macrophage efferocytosis and clearance of inflammation during chronic pancreatitis development. Cell Death Dis. 2022;13(10):893. doi:10.1038/s41419-022-05322-6
   PubMed Web of Science ®Google Scholar
• Peter C, Waibel M, Keppeler H, et al. Release of lysophospholipid ‘find-me’ signals during apoptosis requires the ATP-binding cassette transporter A1. Autoimmunity. 2012;45(8):568–573. doi:10.3109/08916934.2012.719947
   PubMed Web of Science ®Google Scholar
• Zhu K, Baudhuin LM, Hong G, et al. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem. 2001;276(44):41325–41335. doi:10.1074/jbc.M008057200
   PubMed Web of Science ®Google Scholar
• Peter C, Waibel M, Radu CG, et al. Migration to apoptotic “find-me” signals is mediated via the phagocyte receptor G2A. J Biol Chem. 2008;283(9):5296–5305. doi:10.1074/jbc.M706586200
   PubMed Web of Science ®Google Scholar
• Cartier A, Hla T. Sphingosine 1-phosphate: lipid signaling in pathology and therapy. Science. 2019;366(6463). doi:10.1126/science.aar5551
   PubMed Web of Science ®Google Scholar
• Bazan JF, Bacon KB, Hardiman G, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature. 1997;385(6617):640–644. doi:10.1038/385640a0
   PubMed Web of Science ®Google Scholar
• Imai T, Hieshima K, Haskell C, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 1997;91(4):521–530. doi:10.1016/s0092-8674(00)80438-9
   PubMed Web of Science ®Google Scholar
• Idzko M, Ferrari D, Eltzschig HK. Nucleotide signalling during inflammation. Nature. 2014;509(7500):310–317. doi:10.1038/nature13085
   PubMed Web of Science ®Google Scholar
• Jorquera G, Meneses-Valdés R, Rosales-Soto G, et al. High extracellular ATP levels released through pannexin-1 channels mediate inflammation and insulin resistance in skeletal muscle fibres of diet-induced obese mice. Diabetologia. 2021;64(6):1389–1401. doi:10.1007/s00125-021-05418-2
   PubMed Web of Science ®Google Scholar
• Tajbakhsh A, Yousefi F, Abedi SM, et al. The cross-talk between soluble “Find me” and “Keep out” signals as an initial step in regulating efferocytosis. J Cell Physiol. 2022;237(8):3113–3126. doi:10.1002/jcp.30770
   PubMed Web of Science ®Google Scholar
• Segawa K, Nagata S. An apoptotic ‘Eat Me’ signal: phosphatidylserine exposure. Trends Cell Biol. 2015;25(11):639–650. doi:10.1016/j.tcb.2015.08.003
   PubMed Web of Science ®Google Scholar
• Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148(7):2207–2216.
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Karisola P, Peña-Cruz V, et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity. 2007;27(6):927–940. doi:10.1016/j.immuni.2007.11.011
   PubMed Web of Science ®Google Scholar
• DeKruyff RH, Bu X, Ballesteros A, et al. T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J Immunol. 2010;184(4):1918–1930. doi:10.4049/jimmunol.0903059
   PubMed Web of Science ®Google Scholar
• Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. Identification of Tim4 as a phosphatidylserine receptor. Nature. 2007;450(7168):435–439. doi:10.1038/nature06307
   PubMed Web of Science ®Google Scholar
• Lee SJ, Park SY, Jung MY, Bae SM, Kim IS. Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver. Blood. 2011;117(19):5215–5223. doi:10.1182/blood-2010-10-313239
   PubMed Web of Science ®Google Scholar
• He M, Kubo H, Morimoto K, et al. Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep. 2011;12(4):358–364. doi:10.1038/embor.2011.28
   PubMed Web of Science ®Google Scholar
• Lankry D, Rovis TL, Jonjic S, Mandelboim O. The interaction between CD300a and phosphatidylserine inhibits tumor cell killing by NK cells. Eur J Immunol. 2013;43(8):2151–2161. doi:10.1002/eji.201343433
   PubMed Web of Science ®Google Scholar
• Murakami Y, Tian L, Voss OH, Margulies DH, Krzewski K, Coligan JE. CD300b regulates the phagocytosis of apoptotic cells via phosphatidylserine recognition. Cell Death Differ. 2014;21(11):1746–1757. doi:10.1038/cdd.2014.86
   PubMed Web of Science ®Google Scholar
• Tao H, Yancey PG, Babaev VR, et al. Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis. J Lipid Res. 2015;56(8):1449–1460. doi:10.1194/jlr.M056689
   PubMed Web of Science ®Google Scholar
• Lala T, Doan JK, Takatsu H, Hartzell HC, Shin HW, Hall RA. Phosphatidylserine exposure modulates adhesion GPCR BAI1 (ADGRB1) signaling activity. J Biol Chem. 2022;298(12):102685. doi:10.1016/j.jbc.2022.102685
   PubMedGoogle Scholar
• Vago JP, Amaral FA, van de Loo FAJ. Resolving inflammation by TAM receptor activation. Pharmacol Ther. 2021;227:107893. doi:10.1016/j.pharmthera.2021.107893
   PubMed Web of Science ®Google Scholar
• Kourtzelis I, Li X, Mitroulis I, et al. DEL-1 promotes macrophage efferocytosis and clearance of inflammation. Nat Immunol. 2019;20(1):40–49. doi:10.1038/s41590-018-0249-1
   PubMed Web of Science ®Google Scholar
• Akakura S, Singh S, Spataro M, et al. The opsonin MFG-E8 is a ligand for the alphavbeta5 integrin and triggers DOCK180-dependent Rac1 activation for the phagocytosis of apoptotic cells. Exp Cell Res. 2004;292(2):403–416. doi:10.1016/j.yexcr.2003.09.011
   PubMed Web of Science ®Google Scholar
• Jun JI, Kim KH, Lau LF. The matricellular protein CCN1 mediates neutrophil efferocytosis in cutaneous wound healing. Nat Commun. 2015;6:7386. doi:10.1038/ncomms8386
   PubMed Web of Science ®Google Scholar
• Maiti SN, Balasubramanian K, Ramoth JA, Schroit AJ. Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members. J Biol Chem. 2008;283(7):3761–3766. doi:10.1074/jbc.M704990200
   PubMed Web of Science ®Google Scholar
• McShane L, Tabas I, Lemke G, Kurowska-Stolarska M, Maffia P. TAM receptors in cardiovascular disease. Cardiovasc Res. 2019;115(8):1286–1295. doi:10.1093/cvr/cvz100
   PubMed Web of Science ®Google Scholar
• Greenberg ME, Sun M, Zhang R, Febbraio M, Silverstein R, Hazen SL. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med. 2006;203(12):2613–2625. doi:10.1084/jem.20060370
   PubMed Web of Science ®Google Scholar
• Majai G, Sarang Z, Csomós K, Zahuczky G, Fésüs L. PPARgamma-dependent regulation of human macrophages in phagocytosis of apoptotic cells. Eur J Immunol. 2007;37(5):1343–1354. doi:10.1002/eji.200636398
   PubMed Web of Science ®Google Scholar
• Kim SJ, Gershov D, Ma X, Brot N, Elkon KB. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med. 2002;196(5):655–665. doi:10.1084/jem.20020542
   PubMed Web of Science ®Google Scholar
• Gardai SJ, McPhillips KA, Frasch SC, et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell. 2005;123(2):321–334. doi:10.1016/j.cell.2005.08.032
   PubMed Web of Science ®Google Scholar
• Ogden CA, deCathelineau A, Hoffmann PR, et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med. 2001;194(6):781–795. doi:10.1084/jem.194.6.781
   PubMed Web of Science ®Google Scholar
• Bradley CA. CD24 - a novel ‘don’t eat me’ signal. Nat Rev Cancer. 2019;19(10):541. doi:10.1038/s41568-019-0193-x
   PubMed Web of Science ®Google Scholar
• Brown S, Heinisch I, Ross E, Shaw K, Buckley CD, Savill J. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature. 2002;418(6894):200–203. doi:10.1038/nature00811
   PubMed Web of Science ®Google Scholar
• Kojima Y, Volkmer JP, McKenna K, et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature. 2016;536(7614):86–90. doi:10.1038/nature18935
   PubMed Web of Science ®Google Scholar
• Marasco M, Berteotti A, Weyershaeuser J, et al. Molecular mechanism of SHP2 activation by PD-1 stimulation. Sci Adv. 2020;6(5):eaay4458. doi:10.1126/sciadv.aay4458
   PubMed Web of Science ®Google Scholar
• Barkal AA, Weiskopf K, Kao KS, et al. Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy. Nat Immunol. 2018;19(1):76–84. doi:10.1038/s41590-017-0004-z
   PubMed Web of Science ®Google Scholar
• Richards DM, Endres RG. The mechanism of phagocytosis: two stages of engulfment. Biophys J. 2014;107(7):1542–1553. doi:10.1016/j.bpj.2014.07.070
   PubMed Web of Science ®Google Scholar
• Gumienny TL, Brugnera E, Tosello-Trampont AC, et al. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell. 2001;107(1):27–41. doi:10.1016/s0092-8674(01)00520-7
   PubMed Web of Science ®Google Scholar
• Hasegawa H, Kiyokawa E, Tanaka S, et al. DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane. Mol Cell Biol. 1996;16(4):1770–1776. doi:10.1128/mcb.16.4.1770
   PubMed Web of Science ®Google Scholar
• deBakker CD, Haney LB, Kinchen JM, et al. Phagocytosis of apoptotic cells is regulated by a UNC-73/TRIO-MIG-2/RhoG signaling module and armadillo repeats of CED-12/ELMO. Curr Biol. 2004;14(24):2208–2216. doi:10.1016/j.cub.2004.12.029
   PubMed Web of Science ®Google Scholar
• Evans IR, Ghai PA, Urbančič V, Tan KL, Wood W. SCAR/WAVE-mediated processing of engulfed apoptotic corpses is essential for effective macrophage migration in Drosophila. Cell Death Differ. 2013;20(5):709–720. doi:10.1038/cdd.2012.166
   PubMed Web of Science ®Google Scholar
• Hoppe AD, Swanson JA. Cdc42, Rac1, and Rac2 display distinct patterns of activation during phagocytosis. Mol Biol Cell. 2004;15(8):3509–3519. doi:10.1091/mbc.e03-11-0847
   PubMed Web of Science ®Google Scholar
• Park H, Cox D. Cdc42 regulates Fc gamma receptor-mediated phagocytosis through the activation and phosphorylation of Wiskott-Aldrich syndrome protein (WASP) and neural-WASP. Mol Biol Cell. 2009;20(21):4500–4508. doi:10.1091/mbc.e09-03-0230
   PubMed Web of Science ®Google Scholar
• Dart AE, Donnelly SK, Holden DW, Way M, Caron E. Nck and Cdc42 co-operate to recruit N-WASP to promote FcγR-mediated phagocytosis. J Cell Sci. 2012;125(Pt 12):2825–2830. doi:10.1242/jcs.106583
   PubMed Web of Science ®Google Scholar
• Bros M, Haas K, Moll L, Grabbe S. RhoA as a key regulator of innate and adaptive immunity. Cells. 2019;8(7):733. doi:10.3390/cells8070733
   PubMed Web of Science ®Google Scholar
• Marie-Anaïs F, Mazzolini J, Herit F, Niedergang F. Dynamin-actin cross talk contributes to phagosome formation and closure. Traffic. 2016;17(5):487–499. doi:10.1111/tra.12386
   PubMed Web of Science ®Google Scholar
• Stenmark H. Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol. 2009;10(8):513–525. doi:10.1038/nrm2728
   PubMed Web of Science ®Google Scholar
• Rubino M, Miaczynska M, Lippé R, Zerial M. Selective membrane recruitment of EEA1 suggests a role in directional transport of clathrin-coated vesicles to early endosomes. J Biol Chem. 2000;275(6):3745–3748. doi:10.1074/jbc.275.6.3745
   PubMed Web of Science ®Google Scholar
• Horiuchi H, Lippé R, McBride HM, et al. A novel Rab5 GDP/GTP exchange factor complexed to Rabaptin-5 links nucleotide exchange to effector recruitment and function. Cell. 1997;90(6):1149–1159. doi:10.1016/s0092-8674(00)80380-3
   PubMed Web of Science ®Google Scholar
• Toei M, Saum R, Forgac M. Regulation and isoform function of the V-ATPases. Biochemistry. 2010;49(23):4715–4723. doi:10.1021/bi100397s
   PubMed Web of Science ®Google Scholar
• Harrison RE, Bucci C, Vieira OV, Schroer TA, Grinstein S. Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: role of Rab7 and RILP. Mol Cell Biol. 2003;23(18):6494–6506. doi:10.1128/mcb.23.18.6494-6506.2003
   PubMed Web of Science ®Google Scholar
• Johansson M, Lehto M, Tanhuanpää K, Cover TL, Olkkonen VM. The oxysterol-binding protein homologue ORP1L interacts with Rab7 and alters functional properties of late endocytic compartments. Mol Biol Cell. 2005;16(12):5480–5492. doi:10.1091/mbc.e05-03-0189
   PubMed Web of Science ®Google Scholar
• Huynh KK, Eskelinen EL, Scott CC, Malevanets A, Saftig P, Grinstein S. LAMP proteins are required for fusion of lysosomes with phagosomes. EMBO J. 2007;26(2):313–324. doi:10.1038/sj.emboj.7601511
   PubMed Web of Science ®Google Scholar
• Yoon TY, Munson M. SNARE complex assembly and disassembly. Curr Biol. 2018;28(8):R397–r401. doi:10.1016/j.cub.2018.01.005
   PubMed Web of Science ®Google Scholar
• Boada-Romero E, Martinez J, Heckmann BL, Green DR. The clearance of dead cells by efferocytosis. Nat Rev Mol Cell Biol. 2020;21(7):398–414. doi:10.1038/s41580-020-0232-1
   PubMed Web of Science ®Google Scholar
• Han CZ, Juncadella IJ, Kinchen JM, et al. Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation. Nature. 2016;539(7630):570–574. doi:10.1038/nature20141
   PubMed Web of Science ®Google Scholar
• Ying W, Fu W, Lee YS, Olefsky JM. The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities. Nat Rev Endocrinol. 2020;16(2):81–90. doi:10.1038/s41574-019-0286-3
   PubMed Web of Science ®Google Scholar
• Lundberg M, Seiron P, Ingvast S, Korsgren O, Skog O. Insulitis in human diabetes: a histological evaluation of donor pancreases. Diabetologia. 2017;60(2):346–353. doi:10.1007/s00125-016-4140-z
   PubMed Web of Science ®Google Scholar
• Nackiewicz D, Dan M, Speck M, et al. Islet macrophages shift to a reparative state following pancreatic beta-cell death and are a major source of islet insulin-like growth factor-1. iScience. 2020;23(1):100775. doi:10.1016/j.isci.2019.100775
   PubMed Web of Science ®Google Scholar
• Yamagishi S, Fukami K, Matsui T. Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications. Cardiovasc Diabetol. 2015;14:2. doi:10.1186/s12933-015-0176-5
   PubMed Web of Science ®Google Scholar
• Tóbon-Velasco JC, Cuevas E, Torres-Ramos MA. Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets. 2014;13(9):1615–1626. doi:10.2174/1871527313666140806144831
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhu G, Cao X, Dong J, Song F, Niu Y. Blocking AGE-RAGE signaling improved functional disorders of macrophages in diabetic wound. J Diabetes Res. 2017;2017:1428537. doi:10.1155/2017/1428537
   PubMed Web of Science ®Google Scholar
• Ward MG, Li G, Hao M. Apoptotic β-cells induce macrophage reprogramming under diabetic conditions. J Biol Chem. 2018;293(42):16160–16173. doi:10.1074/jbc.RA118.004565
   PubMed Web of Science ®Google Scholar
• Parv K, Westerlund N, Merchant K, Komijani M, Lindsay RS, Christoffersson G. Phagocytosis and efferocytosis by resident macrophages in the mouse pancreas. Front Endocrinol. 2021;12:606175. doi:10.3389/fendo.2021.606175
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177–185. doi:10.1038/nature21363
   PubMed Web of Science ®Google Scholar
• Lindhorst A, Raulien N, Wieghofer P, et al. Adipocyte death triggers a pro-inflammatory response and induces metabolic activation of resident macrophages. Cell Death Dis. 2021;12(6):579. doi:10.1038/s41419-021-03872-9
   PubMed Web of Science ®Google Scholar
• Zatterale F, Longo M, Naderi J, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2019;10:1607. doi:10.3389/fphys.2019.01607
   PubMed Web of Science ®Google Scholar
• Kwon HJ, Kim SN, Kim YA, Lee YH. The contribution of arachidonate 15-lipoxygenase in tissue macrophages to adipose tissue remodeling. Cell Death Dis. 2016;7(6):e2285. doi:10.1038/cddis.2016.190
   PubMedGoogle Scholar
• Arbones-Mainar JM, Johnson LA, Altenburg MK, Kim HS, Maeda N. Impaired adipogenic response to thiazolidinediones in mice expressing human apolipoproteinE4. FASEB J. 2010;24(10):3809–3818. doi:10.1096/fj.10-159517
   PubMed Web of Science ®Google Scholar
• Cash JG, Kuhel DG, Basford JE, et al. Apolipoprotein E4 impairs macrophage efferocytosis and potentiates apoptosis by accelerating endoplasmic reticulum stress. J Biol Chem. 2012;287(33):27876–27884. doi:10.1074/jbc.M112.377549
   PubMed Web of Science ®Google Scholar
• Tóth B, Garabuczi E, Sarang Z, et al. Transglutaminase 2 is needed for the formation of an efficient phagocyte portal in macrophages engulfing apoptotic cells. J Immunol. 2009;182(4):2084–2092. doi:10.4049/jimmunol.0803444
   PubMed Web of Science ®Google Scholar
• Sághy T, Köröskényi K, Hegedűs K, et al. Loss of transglutaminase 2 sensitizes for diet-induced obesity-related inflammation and insulin resistance due to enhanced macrophage c-Src signaling. Cell Death Dis. 2019;10(6):439. doi:10.1038/s41419-019-1677-z
   PubMedGoogle Scholar
• Zhu D, Johnson TK, Wang Y, et al. Macrophage M2 polarization induced by exosomes from adipose-derived stem cells contributes to the exosomal proangiogenic effect on mouse ischemic hindlimb. Stem Cell Res Ther. 2020;11(1):162. doi:10.1186/s13287-020-01669-9
   PubMed Web of Science ®Google Scholar
• Ghahremani Piraghaj M, Soudi S, Ghanbarian H, Bolandi Z, Namaki S, Hashemi SM. Effect of efferocytosis of apoptotic mesenchymal stem cells (MSCs) on C57BL/6 peritoneal macrophages function. Life Sci. 2018;212:203–212. doi:10.1016/j.lfs.2018.09.052
   PubMed Web of Science ®Google Scholar
• Zhao H, Shang Q, Pan Z, et al. Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and beiging in white adipose tissue. Diabetes. 2018;67(2):235–247. doi:10.2337/db17-0356
   PubMed Web of Science ®Google Scholar
• Lee YH, Kim SN, Kwon HJ, Maddipati KR, Granneman JG. Adipogenic role of alternatively activated macrophages in β-adrenergic remodeling of white adipose tissue. Am J Physiol Regul Integr Comp Physiol. 2016;310(1):R55–65. doi:10.1152/ajpregu.00355.2015
   PubMed Web of Science ®Google Scholar
• Ferrannini E, Simonson DC, Katz LD, et al. The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism. 1988;37(1):79–85. doi:10.1016/0026-0495(88)90033-9
   PubMed Web of Science ®Google Scholar
• DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32(2):S157–163. doi:10.2337/dc09-S302
   PubMedGoogle Scholar
• Merz KE, Thurmond DC. Role of skeletal muscle in insulin resistance and glucose uptake. Compr Physiol. 2020;10(3):785–809. doi:10.1002/cphy.c190029
   PubMed Web of Science ®Google Scholar
• Choi EY, Chavakis E, Czabanka MA, et al. Del-1, an endogenous leukocyte-endothelial adhesion inhibitor, limits inflammatory cell recruitment. Science. 2008;322(5904):1101–1104. doi:10.1126/science.1165218
   PubMed Web of Science ®Google Scholar
• Sun JL, Park J, Lee T, Jeong JH, Jung TW. DEL-1 ameliorates high-fat diet-induced insulin resistance in mouse skeletal muscle through SIRT1/SERCA2-mediated ER stress suppression. Biochem Pharmacol. 2020;171:113730. doi:10.1016/j.bcp.2019.113730
   PubMed Web of Science ®Google Scholar
• Kwon CH, Sun JL, Kim MJ, Abd El-Aty AM, Jeong JH, Jung TW. Clinically confirmed DEL-1 as a myokine attenuates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes via AMPK/HO-1- pathway. Adipocyte. 2020;9(1):576–586. doi:10.1080/21623945.2020.1823140
   PubMed Web of Science ®Google Scholar
• Dalli J, Jones CP, Cavalcanti DM, Farsky SH, Perretti M, Rankin SM. Annexin A1 regulates neutrophil clearance by macrophages in the mouse bone marrow. FASEB J. 2012;26(1):387–396. doi:10.1096/fj.11-182089
   PubMed Web of Science ®Google Scholar
• McArthur S, Juban G, Gobbetti T, et al. Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation. J Clin Invest. 2020;130(3):1156–1167. doi:10.1172/jci124635
   PubMed Web of Science ®Google Scholar
• Saclier M, Angelini G, Bonfanti C, Mura G, Temponi G, Messina G. Selective ablation of Nfix in macrophages attenuates muscular dystrophy by inhibiting fibro-adipogenic progenitor-dependent fibrosis. J Pathol. 2022;257(3):352–366. doi:10.1002/path.5895
   PubMed Web of Science ®Google Scholar
• Saclier M, Lapi M, Bonfanti C, Rossi G, Antonini S, Messina G. The transcription factor nfix requires RhoA-ROCK1 dependent phagocytosis to mediate macrophage skewing during skeletal muscle regeneration. Cells. 2020;9(3). doi:10.3390/cells9030708
   PubMed Web of Science ®Google Scholar
• Chinetti G, Gbaguidi FG, Griglio S, et al. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation. 2000;101(20):2411–2417. doi:10.1161/01.cir.101.20.2411
   PubMed Web of Science ®Google Scholar
• Zhang J, Qu C, Li T, Cui W, Wang X, Du J. Phagocytosis mediated by scavenger receptor class BI promotes macrophage transition during skeletal muscle regeneration. J Biol Chem. 2019;294(43):15672–15685. doi:10.1074/jbc.RA119.008795
   PubMed Web of Science ®Google Scholar
• Ikemoto-Uezumi M, Zhou H, Kurosawa T, et al. Increased MFG-E8 at neuromuscular junctions is an exacerbating factor for sarcopenia-associated denervation. Aging Cell. 2022;21(1):e13536. doi:10.1111/acel.13536
   PubMed Web of Science ®Google Scholar
• Li H, Guan K, Liu D, Liu M. Identification of mitochondria-related hub genes in sarcopenia and functional regulation of MFG-E8 on ROS-mediated mitochondrial dysfunction and cell cycle arrest. Food Funct. 2022;13(2):624–638. doi:10.1039/d1fo02610k
   PubMed Web of Science ®Google Scholar
• Varga T, Mounier R, Patsalos A, et al. Macrophage PPARγ, a lipid activated transcription factor controls the growth factor GDF3 and skeletal muscle regeneration. Immunity. 2016;45(5):1038–1051. doi:10.1016/j.immuni.2016.10.016
   PubMed Web of Science ®Google Scholar
• Budai Z, Al-Zaeed N, Szentesi P, et al. Impaired skeletal muscle development and regeneration in transglutaminase 2 knockout mice. Cells. 2021;10(11). doi:10.3390/cells10113089
   PubMed Web of Science ®Google Scholar
• Al-Zaeed N, Budai Z, Szondy Z, Sarang Z. TAM kinase signaling is indispensable for proper skeletal muscle regeneration in mice. Cell Death Dis. 2021;12(6):611. doi:10.1038/s41419-021-03892-5
   PubMed Web of Science ®Google Scholar
• Garabuczi É, Tarban N, Fige É, et al. Nur77 and PPARγ regulate transcription and polarization in distinct subsets of M2-like reparative macrophages during regenerative inflammation. Front Immunol. 2023;14:1139204. doi:10.3389/fimmu.2023.1139204
   PubMed Web of Science ®Google Scholar
• Zheng C, Sui B, Zhang X, et al. Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes. J Extracell Vesicles. 2021;10(7):e12109. doi:10.1002/jev2.12109
   PubMed Web of Science ®Google Scholar
• Song SH, McIntyre SS, Shah H, Veldhuis JD, Hayes PC, Butler PC. Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab. 2000;85(12):4491–4499. doi:10.1210/jcem.85.12.7043
   PubMed Web of Science ®Google Scholar
• Meier JJ, Veldhuis JD, Butler PC. Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. Diabetes. 2005;54(6):1649–1656. doi:10.2337/diabetes.54.6.1649
   PubMed Web of Science ®Google Scholar
• Mu W, Cheng XF, Liu Y, et al. Potential nexus of non-alcoholic fatty liver disease and type 2 diabetes mellitus: insulin resistance between hepatic and peripheral tissues. Front Pharmacol. 2019;9:1566. doi:10.3389/fphar.2018.01566
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Luedde T. Apoptosis and necroptosis in the liver: a matter of life and death. Nat Rev Gastroenterol Hepatol. 2018;15(12):738–752. doi:10.1038/s41575-018-0065-y
   PubMed Web of Science ®Google Scholar
• Jindal A, Bruzzì S, Sutti S, et al. Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH). Exp Mol Pathol. 2015;99(1):155–162. doi:10.1016/j.yexmp.2015.06.015
   PubMed Web of Science ®Google Scholar
• An P, Wei LL, Zhao S, et al. Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. Nat Commun. 2020;11(1):2362. doi:10.1038/s41467-020-16092-0
   PubMed Web of Science ®Google Scholar
• Kim KH, Cheng N, Lau LF. Cellular communication network factor 1-stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis. Hepatol Commun. 2022;6(10):2798–2811. doi:10.1002/hep4.2057
   PubMed Web of Science ®Google Scholar
• Donath MY. Multiple benefits of targeting inflammation in the treatment of type 2 diabetes. Diabetologia. 2016;59(4):679–682. doi:10.1007/s00125-016-3873-z
   PubMed Web of Science ®Google Scholar
• Takemura Y, Ouchi N, Shibata R, et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. J Clin Invest. 2007;117(2):375–386. doi:10.1172/jci29709
   PubMed Web of Science ®Google Scholar
• Luo B, Wang Z, Zhang Z, Shen Z, Zhang Z. The deficiency of macrophage erythropoietin signaling contributes to delayed acute inflammation resolution in diet-induced obese mice. Biochim Biophys Acta Mol Basis Dis. 2019;1865(2):339–349. doi:10.1016/j.bbadis.2018.10.005
   PubMed Web of Science ®Google Scholar
• Li S, Sun Y, Liang CP, et al. Defective phagocytosis of apoptotic cells by macrophages in atherosclerotic lesions of ob/ob mice and reversal by a fish oil diet. Circ Res. 2009;105(11):1072–1082. doi:10.1161/circresaha.109.199570
   PubMed Web of Science ®Google Scholar
• Van Vré EA, Ait-Oufella H, Tedgui A, Mallat Z. Apoptotic cell death and efferocytosis in atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(4):887–893. doi:10.1161/atvbaha.111.224873
   PubMed Web of Science ®Google Scholar
• Yurdagul A Jr, Doran AC, Cai B, Fredman G, Tabas IA. Mechanisms and consequences of defective efferocytosis in atherosclerosis. Front Cardiovasc Med. 2017;4:86. doi:10.3389/fcvm.2017.00086
   PubMed Web of Science ®Google Scholar
• Doddapattar P, Dev R, Ghatge M, et al. Myeloid Cell PKM2 deletion enhances efferocytosis and reduces atherosclerosis. Circ Res. 2022;130(9):1289–1305. doi:10.1161/circresaha.121.320704
   PubMed Web of Science ®Google Scholar
• Kumar D, Pandit R, Yurdagul A Jr. Mechanisms of continual efferocytosis by macrophages and its role in mitigating atherosclerosis. Immunometabolism. 2023;5(1):e00017. doi:10.1097/in9.0000000000000017
   PubMedGoogle Scholar
• Glinton KE, Ma W, Lantz C, et al. Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation. J Clin Invest. 2022;132(9). doi:10.1172/jci140685
   PubMed Web of Science ®Google Scholar
• Jia D, Chen S, Bai P, et al. Cardiac resident macrophage-derived legumain improves cardiac repair by promoting clearance and degradation of apoptotic cardiomyocytes after myocardial infarction. Circulation. 2022;145(20):1542–1556. doi:10.1161/circulationaha.121.057549
   PubMed Web of Science ®Google Scholar
• Suresh Babu S, Thandavarayan RA, Joladarashi D, et al. MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes. Sci Rep. 2016;6:36207. doi:10.1038/srep36207
   PubMed Web of Science ®Google Scholar
• Zhang M, Lin J, Wang S, et al. Melatonin protects against diabetic cardiomyopathy through Mst1/Sirt3 signaling. J Pineal Res. 2017;63(2):e12418. doi:10.1111/jpi.12418
   Web of Science ®Google Scholar
• Nakamura S, Yoshimori T. New insights into autophagosome-lysosome fusion. J Cell Sci. 2017;130(7):1209–1216. doi:10.1242/jcs.196352
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Tabas I, Pajvani UB. Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis. Gastroenterology. 2020;158(7):1913–1928. doi:10.1053/j.gastro.2019.11.311
   PubMed Web of Science ®Google Scholar
• Aitcheson SM, Frentiu FD, Hurn SE, Edwards K, Murray RZ. Skin wound healing: normal macrophage function and macrophage dysfunction in diabetic wounds. Molecules. 2021;26(16):4917. doi:10.3390/molecules26164917
   PubMed Web of Science ®Google Scholar
• Khanna S, Biswas S, Shang Y, et al. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS One. 2010;5(3):e9539. doi:10.1371/journal.pone.0009539
   PubMed Web of Science ®Google Scholar
• Maschalidi S, Mehrotra P, Keçeli BN, et al. Targeting SLC7A11 improves efferocytosis by dendritic cells and wound healing in diabetes. Nature. 2022;606(7915):776–784. doi:10.1038/s41586-022-04754-6
   PubMed Web of Science ®Google Scholar
• Das A, Ghatak S, Sinha M, et al. Correction of MFG-E8 resolves inflammation and promotes cutaneous wound healing in diabetes. J Immunol. 2016;196(12):5089–5100. doi:10.4049/jimmunol.1502270
   PubMed Web of Science ®Google Scholar
• Justynski O, Bridges K, Krause W, et al. Apoptosis recognition receptors regulate skin tissue repair in mice. bioRxiv. 2023. doi:10.1101/2023.01.17.523241
   PubMedGoogle Scholar
• Liu X, Dou G, Li Z, et al. Hybrid biomaterial initiates refractory wound healing via inducing transiently heightened inflammatory responses. Adv Sci. 2022;9(21):e2105650. doi:10.1002/advs.202105650
   Web of Science ®Google Scholar
• Huang JJ, Xia CJ, Wei Y, et al. Annexin A1-derived peptide Ac2-26 facilitates wound healing in diabetic mice. Wound Repair Regen. 2020;28(6):772–779. doi:10.1111/wrr.12860
   PubMed Web of Science ®Google Scholar
• Dardenne C, Salon M, Authier H, et al. Topical aspirin administration improves cutaneous wound healing in diabetic mice through a phenotypic switch of wound macrophages toward an anti-inflammatory and proresolutive profile characterized by LXA4 release. Diabetes. 2022;71(10):2181–2196. doi:10.2337/db20-1245
   PubMed Web of Science ®Google Scholar
• Yang P, Wang X, Wang D, et al. Topical insulin application accelerates diabetic wound healing by promoting anti-inflammatory macrophage polarization. J Cell Sci. 2020;133(19). doi:10.1242/jcs.235838
   Web of Science ®Google Scholar
• Das A, Abas M, Biswas N, et al. A modified collagen dressing induces transition of inflammatory to reparative phenotype of wound macrophages. Sci Rep. 2019;9(1):14293. doi:10.1038/s41598-019-49435-z
   PubMedGoogle Scholar
• Fang L, Chen L, Song M, et al. Naoxintong accelerates diabetic wound healing by attenuating inflammatory response. Pharm Biol. 2021;59(1):252–261. doi:10.1080/13880209.2021.1877735
   PubMed Web of Science ®Google Scholar
• Jiao H, Xiao E, Graves DT. Diabetes and its effect on bone and fracture healing. Curr Osteoporos Rep. 2015;13(5):327–335. doi:10.1007/s11914-015-0286-8
   PubMed Web of Science ®Google Scholar
• Chen M, Lin W, Ye R, Yi J, Zhao Z. PPARβ/δ Agonist alleviates diabetic osteoporosis via regulating M1/M2 macrophage polarization. Front Cell Dev Biol. 2021;9:753194. doi:10.3389/fcell.2021.753194
   PubMed Web of Science ®Google Scholar
• Lu Y, Liu S, Yang P, et al. Exendin-4 and eldecalcitol synergistically promote osteogenic differentiation of bone marrow mesenchymal stem cells through M2 macrophages polarization via PI3K/AKT pathway. Stem Cell Res Ther. 2022;13(1):113. doi:10.1186/s13287-022-02800-8
   PubMed Web of Science ®Google Scholar
• An Y, Zhang H, Wang C, et al. Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis. FASEB J. 2019;33(11):12515–12527. doi:10.1096/fj.201802805RR
   PubMed Web of Science ®Google Scholar
• Lalla E, Papapanou PN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol. 2011;7(12):738–748. doi:10.1038/nrendo.2011.106
   PubMed Web of Science ®Google Scholar
• Li B, Xin Z, Gao S, et al. SIRT6-regulated macrophage efferocytosis epigenetically controls inflammation resolution of diabetic periodontitis. Theranostics. 2023;13(1):231–249. doi:10.7150/thno.78878
   PubMedGoogle Scholar